El Comit\u00e8 d’Acreditaci\u00f3 del Col\u00b7legi Americ\u00e0 de Pat\u00f2legs (CAP o College of American
\nPathologists) ha atorgat la seva acreditaci\u00f3 a ADmit Therapeutics, basat en els resultats de la
\nrecent inspecci\u00f3 realitzada en el lloc com a part dels Programes d’Acreditaci\u00f3 de CAP. ADmit
\nTherapeutics \u00e9s una companyia biotecnol\u00f2gica fundada a finals de 2017 com a spin-off de
\nl’Institut d\u2019Investigaci\u00f3 Biom\u00e8dica de Bellvitge (IDIBELL), i est\u00e0 centrada en el
\ndesenvolupament i la comercialitzaci\u00f3 d’una nova tecnologia de detecci\u00f3 preco\u00e7 de la malaltia
\nd’Alzheimer.
\nADmit Therapeutics \u00e9s un dels m\u00e9s de 8.000 centres acreditats per CAP a tot el m\u00f3n. La
\ndirectora del laboratori, Dra. Marta Blanch, va ser notificada sobre aquest reconeixement
\nnacional i se la va felicitar per l’excel\u00b7l\u00e8ncia dels serveis prestats. “Amb l’acreditaci\u00f3 CAP,
\ngarantim que el nostre laboratori assoleix els m\u00e0xims est\u00e0ndards de qualitat. Aquest
\nassoliment no nom\u00e9s valida el nostre comprom\u00eds per avan\u00e7ar en la investigaci\u00f3 cient\u00edfica, si no
\nque assegura la precisi\u00f3 i credibilitat dels nostres serveis de pron\u00f2stic de la progressi\u00f3 a la
\ndem\u00e8ncia d’Alzheimer en pacients amb deteriorament cognitiu lleu”, ha dit la Dra.<\/p>\n
La Dra. Marta Barrachina, CEO de la companyia, despr\u00e9s de con\u00e8ixer la concessi\u00f3 de
\nl’acreditaci\u00f3, ha dit: “Aquesta acreditaci\u00f3 verifica la precisi\u00f3 i la credibilitat del nostre proc\u00e9s
\nd’an\u00e0lisi i demostra l’enorme esfor\u00e7 realitzat pel nostre equip. Vull destacar el treball excel\u00b7lent
\ndel nostre responsable de qualitat, V\u00edctor Fuentes, i la nostra directora del laboratori, Marta
\nBlanch. \u00c9s un orgull convertir-nos en el primer laboratori acreditat pel CAP a Espanya”.<\/p>\n
El govern federal dels Estats Units reconeix que el Programa d’Acreditaci\u00f3 de CAP de
\nlaboratoris, que es va iniciar a principis dels anys 60, \u00e9s igual o fins i tot m\u00e9s estricte que el
\npropi programa d’inspecci\u00f3 governamental.<\/p>\n
Durant el proc\u00e9s d’acreditaci\u00f3 de CAP, designat per assegurar el m\u00e9s alt est\u00e0ndard d’atenci\u00f3
\npossible per a tots els pacients del laboratori, els inspectors examinen els registres del
\nlaboratori i el control de qualitat dels procediments dels dos anys anteriors. Els inspectors de
\nCAP tamb\u00e9 examinen les qualificacions del personal, l’equip, les instal\u00b7lacions, el programa de
\nseguretat i el registre i l’administraci\u00f3 general del laboratori.<\/p>\n
<\/p>\n
L\u2019Institut d\u2019Investigaci\u00f3 Biom\u00e8dica de Bellvitge (IDIBELL) \u00e9s un centre de recerca en biomedicina creat l\u2019any 2004. Est\u00e0 participat per l\u2019Hospital Universitari de Bellvitge i l\u2019Hospital de Viladecans de l\u2019Institut Catal\u00e0 de la Salut, l\u2019Institut Catal\u00e0 d\u2019Oncologia, la Universitat de Barcelona i l\u2019Ajuntament de l\u2019Hospitalet de Llobregat.<\/em><\/p>\n L\u2019IDIBELL \u00e9s membre del Campus d\u2019Excel\u00b7l\u00e8ncia Internacional de la Universitat de Barcelona HUBc i forma part de la instituci\u00f3 CERCA de la Generalitat de Catalunya. L\u2019any 2009 es va convertir en un dels cinc primers centres d\u2019investigaci\u00f3 espanyols acreditats com a institut d\u2019investigaci\u00f3 sanit\u00e0ria per l\u2019Instituto de Salud Carlos III. A m\u00e9s, forma part del programa \u201cHR Excellence in Research\u201d de la Uni\u00f3 Europea i \u00e9s membre de EATRIS i REGIC. Des de l\u2019any 2018, l\u2019IDIBELL \u00e9s un Centro Acreditado de la Fundaci\u00f3n Cient\u00edfica AECC (FCAECC).<\/em><\/p>\n","protected":false},"excerpt":{"rendered":" El Comit\u00e8 d’Acreditaci\u00f3 del Col\u00b7legi Americ\u00e0 de Pat\u00f2legs (CAP o College of American Pathologists) ha atorgat la seva acreditaci\u00f3 a ADmit Therapeutics, basat en els resultats de la recent inspecci\u00f3 realitzada en el lloc com a part dels Programes d’Acreditaci\u00f3 de CAP. ADmit Therapeutics \u00e9s una companyia biotecnol\u00f2gica fundada a finals de 2017 com a […]<\/p>\n","protected":false},"author":8,"featured_media":26585,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"set","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[493],"tags":[],"class_list":["post-26584","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-innovacio"],"publishpress_future_action":{"enabled":false,"date":"2024-11-28 12:26:20","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category"},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/26584","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/comments?post=26584"}],"version-history":[{"count":4,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/26584\/revisions"}],"predecessor-version":[{"id":26589,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/26584\/revisions\/26589"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media\/26585"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media?parent=26584"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/categories?post=26584"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/tags?post=26584"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}